NARI - Inari Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Inari Medical's activity chart (see below) currently has 170 price targets and 104 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 57.21% of the time, taking 104.87 days on average.

Most recent stock forecast was given by from BTIG on 08-Jan-2025. First documented stock forecast 16-Jun-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Nov-2020

$394

1 years 10 months 13 days ago
(08-Jan-2025)

3/9 (33.33%)

$314.55 (395.91%)

30

Buy Since 12-Oct-2022

$70

$88

1 years 10 months 14 days ago
(07-Jan-2025)

0/2 (0%)

$-9.45 (-11.89%)

Buy Since 20-Jan-2021

$80

$65

1 years 10 months 14 days ago
(07-Jan-2025)

3/5 (60%)

$0.55 (0.69%)

67

Hold Since 01-May-2024

$80

$52

1 years 10 months 14 days ago
(07-Jan-2025)

5/8 (62.5%)

$0.55 (0.69%)

60

Buy Since 19-Jul-2023

$67

1 years 10 months 14 days ago
(07-Jan-2025)

5/5 (100%)

$17.82 (36.23%)

181

Show more analysts

Please expand the browser size to see the chart

What is NARI (Inari Medical) average time for price targets to be met?

On average it took 105 days for the stock forecasts to be reached, with an average price target met ratio of 57.21%.

Which analyst most recently updated their price target on NARI (Inari Medical)?

Which analyst has the most public recommendations on NARI (Inari Medical)?

has 0 price targets and 0 ratings on NARI

Which analyst is the currently most bullish on NARI (Inari Medical)?

Marie Thibault with the highest potential upside of $314.03

Which analyst is the currently most reserved on NARI (Inari Medical)?

Mathew Blackman with the lowest potential downside of -$29.97
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?